Navigation Links
RNL BIO filed Phase II/III Clinical Trial with KFDA to Treat Cerebral Palsy Using Autologous Fat Derived Stem Cells
Date:2/8/2013

SEOUL, South Korea, Feb. 8, 2013 /PRNewswire/ -- RNL BIO CO LTD (RNL) announced today the filing of an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFDA) to initiate clinical trials phase II and III assessing the company's RNL-Astrostem™ stem cell drug in patients with cerebral palsy. The purpose of this study is to assess conclusive efficacy of stem cells for the treatment of cerebral palsy in 45 subjects over 11 months.  The study is to be conducted through Kyung Hee University Hospital at Gangdong and THE Bethesda Hospital.

RNL-Astrostem™, has already completed a phase I trial to assure safety, including tests to rule out toxicity or tumorigenicity.  This trial was conducted at the Seoul National University's Clinical Research Institute.  In addition, the phase I study has confirmed the safety of stem cells infused by IV, as published in a leading peer-reviewed journal, Stem Cells and Development ("Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans," February 2011). In the course of successful safety trials, scientists found significant evidence suggesting the potential for efficacy of stem cells in treatment of cerebral palsy. In addition, a case report with obvious result of improvement was published in another internationally renowned journal. RNL BIO believes that with successful trials and approval of the KFDA, it will be possible to commercialize RNL-Astrostem™ by 2014, revolutionizing the possibility to cure this incurable disease of children, which can only be managed with current technologies.

Cerebral Palsy is caused by non-progressive brain damage from single or multiple defect(s) on the nerve/muscular system and results in disorder in motion and sensory integration. According to Health Insurance Review and Assessment Service, the prevalence of cerebral palsy is 3.5 pe
'/>"/>

SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
2. Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
3. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
4. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
5. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
6. Lotus Pharmaceutical Company Inc. Filed Its Abbreviated New Drug Application (ANDA) Containing a Paragraph IV Certification for a Generic Version of Xenical(R) with the U.S. Food & Drug Administration (FDA)
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
11. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... and NEW YORK , May ... - Over 70% Indonesian men (80 million) ... die annually due to smoking-related conditions; of these, 6% ... million vehicles in Jakarta do ... Indonesia is the fourth most populous country ...
(Date:5/27/2015)... 2015 In a new survey of ... Pharmacy Association (CIPA) found continued demand for ... pharmacies. Approximately 64% of respondents purchase some or all ... pharmacy due to costs of filling the prescriptions. Another ... insurance plan.   Many news reports and ...
(Date:5/27/2015)... -- Nurtur Health, Inc. (Nurtur), a wholly owned subsidiary of ... by Dorland Health,s Case in Point Platinum ... Peach State Health Plan,s teenage members with asthma. ... Awards recognize population health management programs that successfully deliver ... settings in the continuum of care coordination. Nurtur was ...
Breaking Medicine Technology:Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 2Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 3Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 4Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3Nurtur's Asthma Management Program Wins Award from Dorland Health 2
(Date:5/27/2015)... (PRWEB) May 27, 2015 The ... announce a partnership to provide CMSA's Career and ... This collaboration seeks to strengthen the case/care management ... CMSA’s CKP program. The mutually beneficial agreement provides ... individual skills of talent in the healthcare, scientific ...
(Date:5/27/2015)... CA (PRWEB) May 27, 2015 Coco Libre ... will be able to reach for Organic Coconut Water to ... Libre will be available at VIP areas, artist greenrooms, corporate ... be available at area hotels and on festival shuttle buses. ... partner this year,” said Noa Elan, Director of Strategic Partnerships ...
(Date:5/27/2015)... Meadows, IL (PRWEB) May 27, 2015 ... release of its SonarMD Platform, a first-of-its ... monitoring and managing patients with chronic gastrointestinal ... Kosinski, MD, MBA, the application allows physicians ... visits through the ongoing use of electronic ...
(Date:5/27/2015)... SmarterSkin, http://www.smarterskindermatology.com , is taking skin ... that makes it easier for patients to find skin care ... Dr. Sejal Shah is a cosmetic dermatologist based in New ... the test. This revolutionary DNA test uses 16 genetic markers ... , 1. Firmness and elasticity , 2. Glycation ...
(Date:5/27/2015)... CT (PRWEB) May 27, 2015 CRN ... John Prinner as its new Chief Financial Officer. , ... Holdings, and prior to that held financial/operational executive positions ... Intensity, Vivaro Corp., Conversent Communications, Utilicom, and SNET. ... at PricewaterhouseCoopers. , At CRN, Prinner will be able ...
Breaking Medicine News(10 mins):Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:CRN International Names New Chief Financial Officer 2
... targeted therapy against the BRAF/MAPK pathway with immunotherapy shows ... of melanoma, according to results of a preclinical study ... the American Association for Cancer Research. "Our results ... therapy and immunotherapy in the treatment of this most ...
... Center in Hamburg, Germany successfully used transcatheter valve-in-valve implantation ... mitral position. This minimally invasive procedure was used ... at high surgical risk. Full details of the ... Catheterization and Cardiovascular Interventions , a journal published by ...
... more likely to underestimate their preschool children,s weight when ... or gaining weight too fast, a study by the ... The study, published online earlier this ... not hesitate to wield their influence in helping parents ...
... ... holistically reverse symptoms associated with Polycystic Ovarian Syndrome and Insulin Resistance in her e-book. ... (PRWEB) ... are now able to lose weight and achieve hormonal balance without taking any prescription ...
... male-only protein found in rats helps control stress signals in ... -- When it comes to stress, women are twice as ... and/or post-traumatic stress, and now a new study in rats ... evidence in animals that suggests that males benefit from having ...
... Journal of Thoracic Oncology features a study aimed ... nab-paclitaxel with carboplatin as a first-line therapy in patients ... researchers with a data needed to guide a phase ... for patients with NSCLC is carboplatin plus solvent-based paclitaxel. ...
Cached Medicine News:Health News:Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment 2Health News:Elderly patients in need of heart valve replacements have alternative to surgery 2Health News:Pediatricians can help parents recognize overweight preschoolers 2Health News:Pediatricians can help parents recognize overweight preschoolers 3Health News:Women with Polycystic Ovarian Syndrome and Insulin Resistance can Lose Weight and Balance Hormones Naturally with Katie Humphrey's New E-book 2Health News:Females May Be Naturally More Prone to Stress: Animal Study 2Health News:Novel paclitaxel formulation encouraging for treating advanced lung cancer 2
SAFE-T-VAC Coil Packed Suction Catheters Kits, Sterile without Solution...
TOUCH-TROL Suction Catheters Kits, Sterile without Solution...
Sterile, Coil Packed Suction Catheter Mini Tray with (2) Walleted SAFESKIN PURPLE NITRILE Latex-Free Exam Gloves. 14 Fr., DeLee Tip, with Drape...
Our suction kits include a Tri-Flo® suction catheter, a pop-up solution basin and two sturdy, precuffed latex exam gloves in an inner wallet. Infant and pediatric kits (5/6, 8 and 10 Fr) feature ...
Medicine Products: